 |
|
|
| |
Validation of an HCV NS3/4A Sequencing Assay for Evaluating Resistance to Boceprevir, Telaprevir and Protease Inhibitor Candidates in a Clinical Reference Laboratory Setting
|
| |
| |
Reported by Jules Levin
AASLD Nov 4-8 2011 SF
Elizabeth D. Anton, Amber A. Rivera, Yuping Tan, Sunny Choe, Jonathan Toma, Alicia Newton, Jennifer W. Cook, Arne Frantzell, Muzong Cheng, Jeffrey Larson, Jeannette Whitcomb, Christos Petropoulos, Wei Huang and Jacqueline D. Reeves*
Monogram Biosciences, Inc.
South San Francisco, CA, USA
Reprint requests:
Jacqueline Reeves
Monogram Biosciences, Inc.,
345 Oyster Point Blvd.,
South San Francisco, CA 94080
jreeves@monogrambio.com
|
| |
|
|
|
|
|
